White Paper on the Value of Time Savings for Patients and Healthcare Providers of Breast Cancer Therapy: The Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Injection as an Example Christian JackischFederico ManevyJason Shafrin Commentary Open access 05 January 2022 Pages: 833 - 844
Use of Sodium-Glucose Cotransporter-2 Inhibitors in Clinical Practice for Heart Failure Prevention and Treatment: Beyond Type 2 Diabetes. A Narrative Review Shaline Rao Review Open access 09 December 2021 Pages: 845 - 861
Role of Exemestane in the Treatment of Estrogen-Receptor-Positive Breast Cancer: A Narrative Review of Recent Evidence Yongmei WangFanbo JingHaibo Wang Review 06 January 2022 Pages: 862 - 891
An Innovative Approach to Modelling the Optimal Treatment Sequence for Patients with Relapsing–Remitting Multiple Sclerosis: Implementation, Validation, and Impact of the Decision-Making Approach Marjanne A. PienaSonja KroepBen A. van Hout Original Research Open access 18 November 2021 Pages: 892 - 908
Correction to: An Innovative Approach to Modelling the Optimal Treatment Sequence for Patients with Relapsing–Remitting Multiple Sclerosis: Implementation, Validation, and Impact of the Decision-Making Approach Marjanne A. PienaSonja KroepBen A. van Hout Correction 08 January 2022 Pages: 909 - 909
Clinical Experience with Ropeginterferon Alfa-2b in the Off-Label Use for the Treatment of COVID-19 Patients in Taiwan Kuan-Yuan ChenKang-Yun LeePo-Hao Feng Original Research 15 December 2021 Pages: 910 - 922
Fixed-dose Combination of Metoprolol, Telmisartan, and Chlorthalidone for Essential Hypertension in Adults with Stable Coronary Artery Disease: Phase III Study Gouranga SarkarVijay B. GaikwadSuyog Mehta Original Research 17 December 2021 Pages: 923 - 942
The Economic Burden of Recurrence in Triple-Negative Breast Cancer Among Working Age Patients in the United States Jan SielukYan SongKim Marie Hirshfield Original Research 17 December 2021 Pages: 943 - 958
Interpretation of the Meaningfulness of Symptom Reduction with Vibegron in Patients with Overactive Bladder: Analyses from EMPOWUR Jeffrey FrankelDavid StaskinCynthia J. Girman Original Research Open access 18 December 2021 Pages: 959 - 970
Measuring Burden of Illness in Phenylketonuria (PKU): Development of the PKU Symptom Severity and Impacts Scale as a Robust Patient-Reported Outcome Jennifer QuinnAlexandros GeorgiadisElaina Jurecki Original Research Open access 18 December 2021 Pages: 971 - 991
Changes in Platelet Counts and Thrombocytopenia Risk in Patients with Chronic Liver Disease with Different Etiologies Using Real-World Japanese Data Manami YoshidaRyosuke TateishiAtaru Igarashi Original Research Open access 20 December 2021 Pages: 992 - 1003
The Epidemiology of Persons Living with Fontan in 2020 and Projections for 2030: Development of an Epidemiology Model Providing Multinational Estimates Leandra PlappertSusan EdwardsAngela De Martini Original Research Open access 22 December 2021 Pages: 1004 - 1015
Individualized HbA1c Goals, and Patient Awareness and Attainment of Goals in Type 2 Diabetes Mellitus: A Real-World Multinational Survey Dominik LautschRobert BoggsVictoria Higgins Original Research Open access 24 December 2021 Pages: 1016 - 1032
Real-World Management of Hyperkalemia in the Emergency Department: An Electronic Medical Record Analysis Jill DavisRubeen IsraniEric Q. Wu Original Research Open access 27 December 2021 Pages: 1033 - 1044
Using Data on Survival with Idiopathic Pulmonary Fibrosis to Estimate Survival with Other Types of Progressive Fibrosis Interstitial Lung Disease: A Bayesian Framework Bryony LangfordAlex DiamantopoulosMichael Baldwin Original Research Open access 27 December 2021 Pages: 1045 - 1054
Real-World Efficacy and Safety of Apremilast in Belgian Patients with Psoriatic Arthritis: Results from the Prospective Observational APOLO Study Kurt de VlamAdrien Nzeusseu ToukapRik Lories Original Research Open access 03 January 2022 Pages: 1055 - 1067
Real-Life Effectiveness of Apremilast for the Treatment of Psoriasis in Belgium: Results From the Observational OTELO Study Pierre-Dominique GhislainJo LambertSiegfried Segaert Original Research Open access 03 January 2022 Pages: 1068 - 1080
Pirfenidone in Unclassifiable Interstitial Lung Disease: A Subgroup Analysis by Concomitant Mycophenolate Mofetil and/or Previous Corticosteroid Use Michael KreuterToby M. MaherVincent Cottin Brief Report Open access 22 December 2021 Pages: 1081 - 1095
Correction to: Asthma and Chronic Obstructive Pulmonary Disease Overlap According to the Japanese Respiratory Society Diagnostic Criteria: The Prospective, Observational ACO Japan Cohort Study Shu HashimotoRyoko SorimachiMasakazu Ichinose Correction 06 January 2022 Pages: 1096 - 1099